Brief: Cabaletta Bio Receives FDA Fast Track Designation For CABA-201
01/05/2023 13:23
May 1 (Reuters) - Cabaletta Bio Inc CABA.O :
* CABALETTA BIO RECEIVES FDA FAST TRACK DESIGNATION FOR
CABA-201
* CABALETTA BIO RECEIVES FDA FAST TRACK DESIGNATION FOR
CABA-201
Source text for Eikon: ID:nGNX4BQ1VZ
Further company coverage: CABA.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Cabaletta Bio
See all newsBrief: Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Cabaletta Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cabaletta Bio Q2 net loss widens as R&D costs rise
Cabaletta Bio, Inc. expected to post a loss of 37 cents a share - Earnings Preview
Cabaletta Bio Inc expected to post a loss of 37 cents a share - Earnings Preview